Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma
Abstract
PURPOSE Extranodal extension (ENE) is a biomarker in oropharyngeal carcinoma (OPC) but can only be diagnosed via surgical pathology. We applied an automated artificial intelligence (AI) imaging platform integrating lymph node autosegmentation with ENE prediction to determine the prognostic value of the number of predicted ENE nodes. MATERIALS AND METHODS We conducted a multisite, retrospective study of 1,733 OPC patients with pretreatment computed tomography who underwent definitive radiation therapy across three institutions. Malignant lymph nodes were segmented using a validated deep learning auto-segmentation model, and segmented lymph nodes were sequentially processed with a validated ENE prediction model to calculate number of nodes with AI-predicted ENE (AI-ENE) per patient. We evaluated associations of AI-ENE with disease outcomes using site-stratified, multivariable Cox regression, adjusting for human papillomavirus (HPV) status, smoking pack-years, tumor and nodal stage, age, and sex. We evaluated risk-stratification improvement when incorporating AI-ENE into the Radiation Therapy Oncology Group (RTOG)-0129 risk groupings and derived American Joint Committee on Cancer (AJCC) 8th edition staging with Uno C-indices and decision curve analyses. RESULTS Overall, median AI-ENE node number was 1 (range, 0-6). AI-ENE node number was independently associated with poorer distant control (DC; hazard ratio [HR], 1.44 [95% CI, 1.23 to 1.69]; P < .001) and overall survival (OS; HR, 1.30 [95% CI, 1.16 to 1.46]; P < .001). Increasing AI-ENE node number was incrementally associated with worse outcome, particularly DC ( P < .001). C-indices improved in the external data set when incorporating AI-ENE into RTOG-0129 groupings (OS: 0.70 v 0.65; DC: 0.65 v 0.57) and AJCC-8 stage (OS: 0.75 v 0.70; DC: 0.72 v 0.67; P < .001 for each). The largest improvements were observed among HPV-negative patients (C-index: +15% for OS, +14% for DC). CONCLUSION Automated, AI-ENE node number is a novel risk factor for OPC that may better inform pretreatment risk stratification and decision-making.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (21)
Zezhong Ye
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Reza Mojahed-Yazdi
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Anna Zapaishchykova
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Divyanshu Tak
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Maryam Mahootiha
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Juan Carlos Climent Pardo
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
John Zielke
Yining Zha
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Christian Guthier
Roy B. Tishler
Danielle N. Margalit
Jonathan D. Schoenfeld
Robert I. Haddad
Ravindra Uppaluri
Benjamin Haibe-Kains
Clifton D. Fuller
Division of Radiation Oncology, Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX
Mohamed Naser
Barbara A. Burtness
Department of Medicine and Yale Cancer Center, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
Hugo J.W.L. Aerts
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Frank Hoebers
Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA
Benjamin H. Kann